PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28199020-5	2017	Therefore, we administered gemfibrozil (gem), an food and drug administration (FDA)-approved lipid-lowering drug, which has been shown to stimulate lysosomal biogenesis and induce anti-inflammation, orally, at a dose of 7.5 mg/kg body wt/day to Cln2(-/-) mice.	Gemfibrozil	27-38	tripeptidyl peptidase I	Mus musculus	245-249	
28199020-6	2017	We observed that gem-fed Cln2(-/-) mice lived longer by more than 10 weeks and had better motor activity compared to vehicle (0.1% Methyl cellulose) treatment.	Gemfibrozil	17-20	tripeptidyl peptidase I	Mus musculus	25-29	
22989886-0	2012	Gemfibrozil and fenofibrate, Food and Drug Administration-approved lipid-lowering drugs, up-regulate tripeptidyl-peptidase 1 in brain cells via peroxisome proliferator-activated receptor alpha: implications for late infantile Batten disease therapy.	Gemfibrozil	0-11	tripeptidyl peptidase I	Mus musculus	101-124	
22989886-4	2012	This study reveals a novel use of gemfibrozil and fenofibrate, Food and Drug Administration-approved lipid-lowering drugs, in up-regulating TPP1 in brain cells.	Gemfibrozil	34-45	tripeptidyl peptidase I	Mus musculus	140-144	
22989886-5	2012	Both gemfibrozil and fenofibrate up-regulated mRNA, protein, and enzymatic activity of TPP1 in primary mouse neurons and astrocytes as well as human astrocytes and neuronal cells.	Gemfibrozil	5-16	tripeptidyl peptidase I	Mus musculus	87-91	
22989886-8	2012	Accordingly, all-trans-retinoic acid, alone or together with gemfibrozil, up-regulated TPP1.	Gemfibrozil	61-72	tripeptidyl peptidase I	Mus musculus	87-91